Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors

The purpose of this international study is to try to predict which patients are more likely to have side effects from radiotherapy


Weiss medal awarded to Prof. dr. Catharine West!

Professor of Radiation Biology , Catharine West, from the Institute of Cancer Sciences and also the chief investigator from the REQUITE study, has recently been awarded the 2016 Weiss medal by the Association for Radiation Research.

Professor West will formally receive the award at the Association’s annual meeting in July where she will also present the award lecture.

Great support for Dr. Tim Ward and PRDA!

Dr. Tim Ward, a member of the REQUITE Patient Advisory Group, finished the Greater Manchester Marathon on the 10th of April this year. He ran the Marathon with a charity close to his heart: the PRDA, Pelvic Radiation Disease Association, a charity formed of volunteer patients, carers and health professionals who want to help people who are suffering from problems after pelvic radiotherapy - most common in rectal, gynaecological, bladder and prostate cancer patients.

First REQUITE research paper accepted for publication in the International Journal of Radiation Oncology, Biology, Physics!

The REQUITE manuscript: "Pitfalls in prediction modelling for normal tissue toxicity in radiation therapy: an illustration with the ISE and MARIE cohorts", Chamberlain Mbah, Hubert Thierens, Olivier Thas, Jan De Neve, Jenny Chang-Claude, Petra Seibold, Akke Botma, Catharine West, Kim De Ruyck, has been accepted for publication in the International Journal of Radiation Oncology, Biology, Physics.

Oral presentation at Association Of Breast Surgery Conference & AGM!

The Association of Breast Surgery is the association representing healthcare professionals treating malignant and benign breast disease in the UK, Ireland and worldwide. It focuses on education, audit and guidelines to enhance the treatment of patients with breast disease. In 2016 the ABS Conference & AGM will be held at Manchester Central on the 16th & 17th May.

Older news




DEGRO 2016: Innovationen für den Patienten

The German Society for Radiation oncology meeting. In cooperation with the Austrian society for radiation oncology, radiobiology and medical Radiophysics (ÖGRO). For more information click here.

Thursday, 16 June, 2016 to Sunday, 19 June, 2016
Congress Center Rosengarten Mannheim
Rosengartenplatz 2
68161 mannheim

HEC 2016

This is one conference joining the activities of four scientific disciplines: 
Medical Informatics (MIE2016), Medical Biometry, Bioinformatics, Epidemiology and Health Data Management.
It will serve as an important scientific forum for the exchange of new ideas and applications to strengthen health sciences on a national and international level.

Sunday, 28 August, 2016 to Friday, 2 September, 2016
Ludwig-Maximilians-University Munich
Geschwister-Scholl-Platz 1
80539 Munich

2016 World Cancer Congress

The World Cancer Congress is run by the Union for International Cancer Control (UICC) and takes place every two years in a different country, always hosted by a UICC member organisation. The conference is aligned with UICC's purpose statement of uniting the cancer community, to reduce the global cancer burden, to promote greater equity and to integrate cancer into the world's health and development agenda. 

Monday, 31 October, 2016 to Thursday, 3 November, 2016
Palais des congrès
2 Place de la Porte Maillot
75017 Paris